

There seems to be a headway in the fight against the COVID-19 pandemic as Russia has completed the first ever clinical trials of vaccine on humans.

There have been reasonably convincing studies showing that masks stop some of the particles that might carry the virus out of people’s mouths. (PTI)


Report by researchers at CSIR is the first that highlights SARS-CoV-2 may target the PBC of the brainstem that controls respiration and causes respiratory collapse of Covid-19 patients, the statement added.

According to a report in news agency ANI, Balkrishna said that a trial was conducted on hundreds of Covid-19 patients and that the medicine has yielded “100% favourable results.”

The analysis shows that when the number of infected becomes equal to those removed from circulation by recovery and death, the coefficient will reach the 100 per cent threshold and the epidemic will be “extinguished”.

IIM Ranchi partners with Masai to introduce product management executive program

ISRO launches Junior Research Fellowship program, applications open until July 11

Facebook gets AI makeover as Meta rolls out smarter search, creative tools

India's desi Tomahawk aces first test, boosts long-range strike capability

India signs MoUs with Slovakia to boost education, research, and digital technology ties

IIM Ranchi partners with Masai to introduce product management executive program

Doctor's prescription now mandatory for all cough syrup purchases
.jpg&w=256&q=75)
Mumbai still awaits monsoon as India grapples with a 64% rainfall deficit

NEET UG 2026 re-exam: Telegram restrictions imposed to curb fake paper leak claims

NCERT restores original Dancing Girl image in Class 9 textbook after backlash
Copyright© educationpost.in 2024 All Rights Reserved.
Designed and Developed by @Pyndertech